{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA077651"
        ],
        "brand_name": [
          "ZONISAMIDE"
        ],
        "generic_name": [
          "ZONISAMIDE"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-128",
          "68462-129",
          "68462-130"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ZONISAMIDE"
        ],
        "rxcui": [
          "314285",
          "403966",
          "403967"
        ],
        "spl_id": [
          "c00ccc2d-52c6-4a11-a310-d8db25ca3928"
        ],
        "spl_set_id": [
          "fe15e56e-8b86-4a65-825c-31d37dd81612"
        ],
        "package_ndc": [
          "68462-128-01",
          "68462-128-05",
          "68462-129-01",
          "68462-129-05",
          "68462-130-01",
          "68462-130-05"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462130018",
          "0368462129012",
          "0368462128015"
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "M0020790",
          "N0000000235",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_cs": [
          "Sulfonamides [CS]"
        ],
        "pharm_class_moa": [
          "Carbonic Anhydrase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "459384H98V"
        ]
      },
      "product_type": "Drugs",
      "event_id": "90029",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide",
      "recall_number": "D-0792-2022",
      "product_description": "Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01",
      "product_quantity": "12,003 bottles",
      "reason_for_recall": "cGMP deviations",
      "recall_initiation_date": "20220425",
      "center_classification_date": "20220427",
      "report_date": "20220504",
      "code_info": "Lot #: 29200064, Exp 5/31/2023",
      "more_code_info": ""
    }
  ]
}